ArticleClinical cancer research : an official journal of the American Association for Cancer Research2009

CEACAM5-targeted therapy of human colonic and pancreatic cancer xenografts with potent labetuzumab-SN-38 immunoconjugates.

Serengulam V Govindan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.